Surgery Partners, Inc. (NASDAQ:SGRY) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the ten brokerages that are presently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $36.56.

Several equities research analysts have recently commented on SGRY shares. Royal Bank of Canada reduced their target price on shares of Surgery Partners from $49.00 to $35.00 and set an "outperform" rating on the stock in a research note on Wednesday, November 20th. KeyCorp started coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a "sector weight" rating on the stock. UBS Group initiated coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a "buy" rating and a $38.00 price objective for the company. JPMorgan Chase & Co. decreased their price target on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research report on Tuesday, December 3rd. Finally, Macquarie reiterated an "outperform" rating and issued a $34.00 price objective on shares of Surgery Partners in a research report on Tuesday, November 19th.

Hedge Funds Weigh In On Surgery Partners

Institutional investors have recently modified their holdings of the stock. KBC Group NV raised its position in shares of Surgery Partners by 31.8% during the third quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after purchasing an additional 576 shares during the period. Quarry LP raised its holdings in Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company's stock worth $73,000 after buying an additional 1,760 shares during the period. Point72 Asia Singapore Pte. Ltd. raised its holdings in Surgery Partners by 747.6% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock worth $124,000 after buying an additional 3,379 shares during the period. Creative Planning bought a new position in Surgery Partners in the third quarter valued at approximately $258,000. Finally, Versor Investments LP acquired a new position in shares of Surgery Partners in the third quarter valued at approximately $271,000.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY traded up $0.59 during midday trading on Wednesday, reaching $21.23. 656,543 shares of the company's stock were exchanged, compared to its average volume of 842,029. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.66 and a current ratio of 1.80. The company's 50 day simple moving average is $23.48 and its two-hundred day simple moving average is $27.41. Surgery Partners has a 12 month low of $19.50 and a 12 month high of $35.29. The firm has a market capitalization of $2.70 billion, a PE ratio of -44.23, a price-to-earnings-growth ratio of 17.40 and a beta of 2.58.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same period in the previous year, the firm posted $0.15 earnings per share. The firm's revenue for the quarter was up 14.3% compared to the same quarter last year. Equities research analysts expect that Surgery Partners will post 0.71 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.